News
12-10-2010, 12:51 AM
The long-awaited results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer, the AZURE trial, will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 8-12.
More... (http://www.news-medical.net/news/20101210/Results-of-Adjuvant-Treatment-with-Zoledronic-Acid-in-Stage-IIIII-Breast-Cancer-to-be-presented-at-symposium.aspx)
More... (http://www.news-medical.net/news/20101210/Results-of-Adjuvant-Treatment-with-Zoledronic-Acid-in-Stage-IIIII-Breast-Cancer-to-be-presented-at-symposium.aspx)